Diagnosis and Management of Children With Tuberous Sclerosis Complex

Area of Science:

• Genetics and Medicine
• Neurology
• Pediatrics

Background:

• Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by variants in TSC1 or TSC2 genes.
• It presents with benign tumors (hamartomas) in various organs and neurological complications like epilepsy and developmental disabilities.
• TSC affects multiple systems, including the brain, kidneys, skin, and heart, with variable onset and severity.

Purpose of the Study:

• To describe a multidisciplinary model of care for Tuberous Sclerosis Complex (TSC).
• To emphasize early detection, diagnosis, and active surveillance of seizures in TSC.
• To outline lifelong management guidelines for TSC-specific manifestations.

Main Methods:

• Review of clinical presentation, diagnosis, and genetic basis of TSC.
• Discussion of genetic counseling's role in TSC management.
• Emphasis on surveillance and management strategies for TSC-related issues.

Main Results:

• TSC necessitates a multidisciplinary approach for comprehensive patient care.
• Early diagnosis and intervention, including precision medicine (mTOR inhibitors), can mitigate disease burden.
• Active surveillance and management of seizures are crucial for affected children.

Conclusions:

• A structured, multidisciplinary model of care is essential for optimizing outcomes in Tuberous Sclerosis Complex.
• Lifelong surveillance and tailored management of neurological, developmental, and organ-specific issues are critical.
• Precision medicine offers targeted therapeutic options for epilepsy and tumors in TSC.